Aligos Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aligos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Aligos Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $300K, unchanged year-over-year.
  • Aligos Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.29M, a 23.6% decline year-over-year.
  • Aligos Therapeutics, Inc. annual Depreciation for 2023 was $1.56M, a 32.4% decline from 2022.
  • Aligos Therapeutics, Inc. annual Depreciation for 2022 was $2.31M, a 23.6% decline from 2021.
  • Aligos Therapeutics, Inc. annual Depreciation for 2021 was $3.02M, a 10.4% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.56M -$747K -32.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $2.31M -$713K -23.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $3.02M +$284K +10.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $2.74M +$1.34M +95.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $1.4M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.